Clinical Trial: A Randomised Trial Investigating the Role of ERBT Plus Intravesical BCG in Intermediate-Risk or High-Risk NMBC

U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07724886) titled 'A Randomised Trial Investigating the Role of ERBT Plus Intravesical BCG in Intermediate-Risk or High-Risk NMBC' on April 22.

Brief Summary: This is a prospective, multi-centre randomised trial comparing between cTURBT plus 1-year BCG therapy, and ERBT plus 1-year BCG therapy, in patients with intermediate-risk or high-risk NMIBC.

Study Start Date: July 01

Study Type: INTERVENTIONAL

Condition: Bladder Cancer

Intervention: PROCEDURE: Conventional Transurethral Resection of Bladder Tumour

Conventional TURBT is performed by resecting the bladder tumour in a piecemeal manner with a top-down approach. The bladder tumour specimen is...